1,441 results match your criteria: "Glaucoma Hyphema"

Background: Trabeculectomy (TRAB) traditionally has been the gold-standard surgical treatment for primary open-angle glaucoma (POAG), while gonioscopy-assisted transluminal trabeculotomy (GATT) is an emerging minimally invasive surgery used for the treatment of various open-angle glaucoma (OAG) types. In this study, we aimed to compare the efficacy and safety between GATT and TRAB for the treatment of POAG.

Methods: This cohort study included eyes with POAG that underwent a single GATT (30 eyes) or TRAB (34 eyes).

View Article and Find Full Text PDF

Purpose: This study aims to present a case involving intermittent bleeding from the iridocorneal angle following gonioscopy-assisted transluminal trabeculotomy (GATT) surgery, followed by the development of ghost cell glaucoma (GCG).

Methods: A 25-year-old man with a history of post-traumatic angle recession glaucoma underwent uneventful 360° GATT surgery.

Results: Two weeks after the surgery, while the reason for the incomplete resolution of hyphema remained unclear, intermittent bleeding from the iridocorneal angle and hemorrhage in the inferior vitreous were observed during the patient's follow-up examination.

View Article and Find Full Text PDF

Purpose: To assess the outcome of combined phacoemulsification and 360-degree suture trabeculotomy ab externo in chronic angle closure glaucoma using a modified technique.

Methods: This is a retrospective clinical study that included 60 eyes of 60 patients who had undergone combined phacoemulsification and 360-degree suture trabeculotomy ab externo for the treatment of primary chronic angle closure glaucoma. The patients were divided into two groups.

View Article and Find Full Text PDF

Purpose: To evaluate the effectiveness and safety of ab-interno canaloplasty (ABiC) for managing intraocular pressure (IOP) in patients following keratoplasty over a three-year period.

Methods: This retrospective analysis focused on post-keratoplasty patients treated with ABiC with the iTrack microcatheter (Nova Eye Medical, Fremont, CA, USA) at a single institution. The study assessed the procedure's impact on IOP control, graft survival, and reliance on topical hypotensive medications, with additional observation for any postoperative complications.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to assess the effectiveness and safety of a new surgical method called transconjunctival XEN® 45 gel stent implantation in treating primary open-angle glaucoma (POAG).
  • A total of 31 patients underwent the procedure, experiencing an average decrease in intraocular pressure from 25.3 mm Hg pre-surgery to 15.9 mm Hg post-surgery, with most not needing additional medications by the one-month follow-up.
  • The results suggest that this surgical technique is both safe and effective, offering a timely alternative for patients with POAG needing surgical intervention earlier in their treatment process.
View Article and Find Full Text PDF

Aim And Background: The OMNI surgical system allows for 360° canaloplasty and trabeculotomy for patients with glaucoma, either as a standalone procedure or in combination with cataract surgery. There is currently limited evidence on its use in forms of angle-closure glaucoma, though other microinvasive glaucoma surgeries have been used. We present three patients with angle closure who underwent the procedure.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the occurrence of hyphema (bleeding in the anterior chamber) after PRESERFLO MicroShunt surgery in glaucoma patients and its connection to the tube insertion position.
  • Out of 66 eyes reviewed, 23 experienced hyphema, equating to a 35% occurrence rate, with bleeding observed during surgery in 8 cases.
  • Despite the high frequency of hyphema, all cases resolved within weeks with stable intraocular pressure and visual acuity, highlighting the need to inform patients about this risk before surgery.
View Article and Find Full Text PDF

Delayed onset Spontaneous Hyphema after OMNI® Surgical System.

J Glaucoma

October 2024

Department of Ophthalmology, Mayo Clinic 200 First St SW, Rochester, MN, 55905.

Minimally invasive glaucoma surgery (MIGS) offers options for glaucoma treatment that have generally improved safety profiles compared with filtering surgery. MIGS vary in design and procedure, but all angle-based MIGS function by bypassing or removing aqueous humor outflow resistance at the level of the trabecular meshwork. This can lower intraocular pressure but also remove the blood-aqueous barrier.

View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the safety and effectiveness of ab externo canaloplasty in Polish Caucasian patients with glaucoma over a three-year follow-up, focusing on intraocular pressure and medication use.
  • - Results showed a significant reduction in mean intraocular pressure from 19.23 mmHg to 14.52 mmHg and a decrease in medication burden, with 58.7% achieving complete success by the end of the study.
  • - Common complications included incomplete cannulation and hyphema, but overall, the procedure demonstrated a favorable safety profile with few needing additional surgery or medication afterward.
View Article and Find Full Text PDF

Background: The Hydrus Microstent has been shown to be efficacious in the treatment of Open-angle Glaucoma. We previously reported 1-year results of the Hydrus Microstent in Black and Afro-Latino patients.

Objective: Here we report two-year results of the Hydrus Microstent in Black and Afro-Latino patients with mild to moderate open-angle glaucoma.

View Article and Find Full Text PDF

Purpose: To evaluate the performance of a large language model (LLM) in classifying electronic health record (EHR) text, and to use this classification to evaluate the type and resolution of hemorrhagic events (HEs) after microinvasive glaucoma surgery (MIGS).

Design: Retrospective cohort study.

Participants: Eyes from the Bascom Palmer Glaucoma Repository.

View Article and Find Full Text PDF

Uveitis glaucoma hyphema syndrome as a result of glaucoma implant: A case report.

World J Clin Cases

October 2024

Glaucoma and Cataract, Department of Ophthalmology, King Abdulaziz University Hospital, King Saud University, Riyadh 15112, Saudi Arabia.

Article Synopsis
  • * A case was reported involving a 55-year-old woman who developed hyphema and pigmentation after AGV implantation, leading to the rare UGH syndrome, which was not previously documented as a complication of this surgery.
  • * Following a second surgery to adjust the AGV tube, the patient's IOP improved, and she showed no further signs of complications, highlighting the importance of regular follow-up for patients after AGV implantation.
View Article and Find Full Text PDF

Purpose: To report the rates and risk factors for layered hyphemas after goniotomy (PG) and trabecular bypass stent (PTBS) surgery combined with phacoemulsification.

Methods: Patient data was obtained using a retrospective chart review from adult patients (18 years of age or older) undergoing either PG or PTBS at the West Virginia University Eye Institute between 2013 and 2023. Generalized estimating equations were used to identify significant predictors of layered hyphema on post-operative day one.

View Article and Find Full Text PDF

Introduction: To assess the efficacy and safety of retrocorneal membrane interception (RMI)-enhanced penetrating canaloplasty in glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE) with open angle or small peripheral anterior synechiae (PAS).

Methods: A series of 13 patients (13 eyes) with GS-ICE and uncontrolled intraocular pressure (IOP) underwent RMI-enhanced penetrating canaloplasty from March 2019 to October 2020. The patients were followed up at one week, 1 month, 3 months, 6 months, and 12 months, postoperatively.

View Article and Find Full Text PDF

Glaucoma is a disease that leads to optic nerve damage and irreversible loss of the visual field. Gonioscopy-assisted transluminal trabeculotomy (GATT) is a minimally invasive glaucoma surgery technique, where the surgeon opens the trabecular network and Schlemm's canal to improve the outflow of the aqueous humor. This method has shown efficacy in reducing intraocular pressure in patients with primary and secondary glaucoma.

View Article and Find Full Text PDF

Bilateral neovascular glaucoma associated with Radium-223 infusions for prostate cancer.

Am J Ophthalmol Case Rep

December 2024

The University of Florida, Department of Ophthalmology, 1600 SW Archer Road, Gainesville, FL, 32608, USA.

Article Synopsis
  • This report discusses two cases of neovascular glaucoma in patients with metastatic prostate cancer after receiving Radium-223 treatment, which typically targets bone metastases.
  • Both patients experienced increased intraocular pressure and required surgery, with one being a previous glaucoma suspect and the other having no relevant eye history.
  • The study suggests that Radium-223 may disrupt blood vessel signaling, potentially causing eye complications like neovascular glaucoma, highlighting a lack of prior reports on this issue in existing literature.
View Article and Find Full Text PDF

[Clinical effect of XEN gel stent implantation or combined with phacoemusification and intraocular lens implantation on glaucoma].

Zhonghua Yan Ke Za Zhi

September 2024

Shenzhen Eye Hospital, Shenzhen Eye Institute, Shenzhen Eye Hospital affiliated to Jinan University, School of Optometry, Shenzhen University, Shenzhen 518040, China.

To evaluate the efficacy and safety of internal XEN gel stent implantation or combined with phacoemusification and intraocular lens (IOL) implantation in the treatment of glaucoma. It was a retrospective case series study. Forty-five patients (28 males and 17 females; 52 eyes) who had different types of glaucoma treated at the Shenzhen Eye Hospital from December 2021 to June 2023 were included.

View Article and Find Full Text PDF

Purpose: To share examination findings of the lens capsule which may act as an indicator for malpositioned intraocular lenses (IOL).

Setting: Single large multi-specialty private practice, Houston, Texas, USA.

Design: Focused, observational case series.

View Article and Find Full Text PDF

To report the surgical safety of reinforced bio-interventional cyclodialysis with scleral allograft reinforcement. This was a consecutive case series of 243 eyes with open-angle glaucoma who underwent a bio-scaffolded cyclodialysis (BSC) procedure for uveoscleral outflow enhancement using allogeneic bio-spacers to maintain patency of the internal filtration conduit. 79% of the eyes underwent concomitant phacoemulsification cataract surgery prior to BSC intervention, while the remaining eyes underwent stand-alone BSC surgery.

View Article and Find Full Text PDF

Background: Implantation of intraocular lens in the capsular bag has become the standard of care in aphakic state. However, in the absence of capsular support, several techniques and intraocular lenses are available. Our study aims to report the safety, efficacy, and clinical outcomes of transconjunctival intrascleral intraocular lens fixation with Yamane's double-needle technique and flanged haptics.

View Article and Find Full Text PDF

Purpose XEN45 Gel Stent and glaucoma drainage device (GDD) implantation is safe and effective for glaucoma treatment and should be taught during glaucoma fellowship training. However, complications may still occur, with potentially sight-threatening consequences. The purpose of this study is to describe the management of complications following a series of XEN45 Gel Stent and GDD surgeries performed over the course of glaucoma fellowship training.

View Article and Find Full Text PDF

Purpose: To report the 2-year efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for the treatment of primary open-angle glaucoma (POAG).

Setting: A single surgical site in China.

Design: This was a prospective, randomized controlled trial.

View Article and Find Full Text PDF

Purpose: The Hydrus microstent was approved by the FDA in August 2018 for use with cataract surgery to reduce IOP in patients with mild to moderate primary open angle glaucoma (POAG). Pivotal clinical trials demonstrated its overall safety and efficacy in lowering IOP. However, malpositioning of the implant can result in uveitis-glaucoma-hyphema (UGH) syndrome necessitating device explantation.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the effectiveness and safety of combining intraocular anti-VEGF injections with Ahmed glaucoma valve implantation (AGVI) for treating neovascular glaucoma (NVG).
  • - A comprehensive review of 14 randomized controlled trials found that the combination treatment significantly lowers postoperative intraocular pressure (IOP) and reduces complications compared to AGVI alone.
  • - Results showed improved treatment outcomes, such as a higher effective rate and decreased need for additional glaucoma medications, indicating that this combined approach is beneficial for patients with NVG.
View Article and Find Full Text PDF